Evaluating LP-10 in Subjects With OLP
Study sponsor: Lipella Pharmaceuticals, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-06-01Estimated
Enrollment · participants24Estimated
Source updated2025-05-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.